A new oral drug designed to improve efficacy of radiotherapy has been shown to be effective and safe as an adjunctive treatment for hard-to-treat cancers.
NCRI 2018: Prostate cancer patients may prioritize the avoidance of side-effects over survival probability
A study examining the perspective of patients recently diagnosed with prostate cancer has revealed that patients may be willing to relinquish some survival probability in order to avoid side-effects and repeat treatments.
Results of a Phase I study have suggested multisite stereotactic body radiotherapy prior to immunotherapy treatment may improve patient outcomes.
A novel viral-gene therapy could improve results from breast reconstruction surgery after cancer treatment by helping healthy tissue protect itself from radiotherapy damage.
Discover whether radiotherapy may have a promising role in synergistically enhancing the systemic response to immune checkpoint inhibition in this editorial from Future Oncology.
Researchers have discovered that a shorter course of radiation using higher doses over fewer days may be a more effective approach for some men with intermediate-risk prostate cancer.
Listen to our interview to find out about the importance of knowledge based oncology and integrating radiotherapy with other treatment modalities such as surgery.
New research highlights the effect of increased autotaxin production in breast adipose tissue on radiotherapy, when treating breast cancer.
Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?
Primary research to evaluate whether Recursive Partitioning Analysis or Graded Prognostic Assessment is more useful to clinicians.
Find out about how the UK’s National Physical Laboratory (NPL) is enabling greater confidence in radiotherapy, leading to accelerated implementation of the most advanced techniques and helping to ensure patients receive the same standard of treatment irrespective of where they receive their treatment.